trending Market Intelligence /marketintelligence/en/news-insights/trending/B_uOtYE-zDQWAodacpOGMQ2 content esgSubNav
In This List

India's Strides Pharma to acquire majority stake in Fair-Med Healthcare

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


India's Strides Pharma to acquire majority stake in Fair-Med Healthcare

Strides Pharma Science Ltd. agreed to acquire a 70% stake in Switzerland-based private pharmaceutical company Fair-Med Healthcare AG for CHF2.2 million.

Bengaluru, India-based Strides Pharma, which manufactures and sells generic medicines, gelatin capsules, ointments and creams, said Fair-Med's market access in Germany, Austria and Switzerland will complement its product portfolio. The acquisition will be made through subsidiary Strides Pharma Global Pte. Ltd.

Fair-Med manufactures generic medicines, including therapies for heart disorders, respiratory diseases and cancer and has a portfolio of more than 30 products.